CD3E and neoplasm: Immunohistochemically (Table 2), tumor cells from all cases were positive for CD3ε and EBER, and 98.8% of cases were positive for the cytotoxic marker T‐cell intracellular antigen‐1/granzyme B. Positive CD56 immunostaining was observed in 72.8% (59/81) of cases.